Editor’s Memo
Peter Wehrwein
Legislation & Regulation
Richard Mark Kirkner
The plaintiffs are now defendants and vice versa in the drawn-out dispute over ACA birth control coverage.
The Payers’ Playbook
Joseph Burns
A MedPage Today blog post suggests that they do. Industry veterans say they’re unaware of bonuses for denials but agree prior auth processes should be more transparent.
Tomorrow’s Medicine
Thomas Morrow, MD
Genentech’s drug, approved late last year, connects two clotting factors to prevent the devastating bleeds in hemophilia patients with inhibitors. The high price may be offset by avoided costs in patients with factor VIII inhibitors.
News & Commentary